What Happened to Ginkgo Bioworks Holdings?
Ticker: DNASPAC Year: 2021
Return
-30.1%
Current Price
$8
Peak Price
$634.56
Trust Size
$1.1B
Summary
Ginkgo Bioworks is a synthetic biology platform company that engineers organisms for customers across industries including pharmaceuticals, food, agriculture, and chemicals. The company went public via SPAC merger with Soaring Eagle Acquisition Corp in 2021 at a $15 billion valuation.
What Happened
Soaring Eagle Acquisition Corp merged with Ginkgo Bioworks in September 2021 at a $15 billion valuation. The stock initially soared but then collapsed as revenue growth disappointed and the company's biosecurity division (acquired during COVID) wound down. Ginkgo has undergone significant restructuring, pivoting toward autonomous labs and AI-driven biology. The stock trades at a fraction of its peak but the company continues to operate.
Timeline
2021-02-22
S-1 Registration Filed